95 related articles for article (PubMed ID: 20463834)
1. Hurthle cell tumours of the thyroid. Personal experience and review of the literature.
Barnabei A; Ferretti E; Baldelli R; Procaccini A; Spriano G; Appetecchia M
Acta Otorhinolaryngol Ital; 2009 Dec; 29(6):305-11. PubMed ID: 20463834
[TBL] [Abstract][Full Text] [Related]
2. Appearance of Hürthle cell carcinoma soon after surgical extirpation of Hürthle cell adenoma and follicular adenoma of the thyroid gland.
Ristevska N; Stojanoski S; Gjorceva DP
Radiol Oncol; 2015 Mar; 49(1):26-31. PubMed ID: 25810698
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the Enigma: A Five-Year Comprehensive Analysis of Hurthle Cell Tumors in South India's Tertiary Care Center.
Sulaiman S; Chirukandath R; Krishnan SK; Rajesh N; Antony M; Mohan K; S S
Cureus; 2024 Mar; 16(3):e57166. PubMed ID: 38681349
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of metastatic Hürthle cell carcinoma to the skull base, cortex, and spine: illustrative case.
Hameed NUF; Hoppe MM; Habib A; Head J; Shanahan R; Gross BA; Narayanan S; Zenonos G; Zinn P
J Neurosurg Case Lessons; 2023 Oct; 6(15):. PubMed ID: 37910014
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience.
Petric R; Gazic B; Besic N
BMC Cancer; 2014 Oct; 14():777. PubMed ID: 25338674
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular features of Hürthle cell carcinoma of the thyroid.
Chindris AM; Casler JD; Bernet VJ; Rivera M; Thomas C; Kachergus JM; Necela BM; Hay ID; Westphal SA; Grant CS; Thompson GB; Schlinkert RT; Thompson EA; Smallridge RC
J Clin Endocrinol Metab; 2015 Jan; 100(1):55-62. PubMed ID: 25259908
[TBL] [Abstract][Full Text] [Related]
7. Hurthle Cell Lesion: Controversies, Challenges, and Debates.
Shawky M; Sakr M
Indian J Surg; 2016 Feb; 78(1):41-8. PubMed ID: 27186039
[TBL] [Abstract][Full Text] [Related]
8. The significance of hurthle cells in thyroid disease.
Cannon J
Oncologist; 2011; 16(10):1380-7. PubMed ID: 21964000
[TBL] [Abstract][Full Text] [Related]
9. The biology and the genetics of Hurthle cell tumors of the thyroid.
Máximo V; Lima J; Prazeres H; Soares P; Sobrinho-Simões M
Endocr Relat Cancer; 2012 Aug; 19(4):R131-47. PubMed ID: 22514109
[TBL] [Abstract][Full Text] [Related]
10. Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management.
Grani G; Lamartina L; Durante C; Filetti S; Cooper DS
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):500-514. PubMed ID: 29102432
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of diagnosis and treatment of 100 patients with Hürthle cell adenoma].
Kang Q; Zhang JX; Gao Y; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1098-1101. PubMed ID: 33331320
[TBL] [Abstract][Full Text] [Related]
12. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
McHenry CR; Sandoval BA
Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
[TBL] [Abstract][Full Text] [Related]
13. Hurthle cell carcinoma: a population-level analysis of 3311 patients.
Goffredo P; Roman SA; Sosa JA
Cancer; 2013 Feb; 119(3):504-11. PubMed ID: 22893587
[TBL] [Abstract][Full Text] [Related]
14. Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis.
Coca-Pelaz A; Rodrigo JP; Shah JP; Sanabria A; Al Ghuzlan A; Silver CE; Shaha AR; Angelos P; Hartl DM; Mäkitie AA; Olsen KD; Owen RP; Randolph GW; Simó R; Tufano RP; Kowalski LP; Zafereo ME; Rinaldo A; Ferlito A
Adv Ther; 2021 Oct; 38(10):5144-5164. PubMed ID: 34423400
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy.
Wenter V; Jellinek A; Unterrainer M; Ahmaddy F; Lehner S; Albert NL; Bartenstein P; Knösel T; Spitzweg C; Ilhan H; Todica A
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2526-2535. PubMed ID: 31410542
[TBL] [Abstract][Full Text] [Related]
16. Rare Occurrence of Incidental Finding of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features in Hürthle Cell Adenoma.
Pigac B; Masic S; Hutinec Z; Masic V
Med Arch; 2018 Nov; 72(5):367-370. PubMed ID: 30524171
[TBL] [Abstract][Full Text] [Related]
17. Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma).
Xiong Y; Zhao Q; Li Z; Wang S; Guo H; Liu Z; Huang T
Oncotarget; 2017 Nov; 8(60):101362-101371. PubMed ID: 29254170
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis.
Vuong HG; Duong UNP; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
World J Surg; 2018 Apr; 42(4):1005-1017. PubMed ID: 28913696
[TBL] [Abstract][Full Text] [Related]
19. Bilateral Renal Metastasis of Hürthle Cell Thyroid Cancer with Discordant Uptake Between I-131 Sodium Iodide and F-18 FDG.
Claimon A; Suh M; Cheon GJ; Lee DS; Kim EE; Chung JK
Nucl Med Mol Imaging; 2017 Sep; 51(3):256-260. PubMed ID: 28878853
[TBL] [Abstract][Full Text] [Related]
20. Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience.
Oluic B; Paunovic I; Loncar Z; Djukic V; Diklic A; Jovanovic M; Garabinovic Z; Slijepcevic N; Rovcanin B; Micic D; Filipovic A; Zivaljevic V
BMC Cancer; 2017 May; 17(1):371. PubMed ID: 28545571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
